Home Biosimilar Antibodies Others CD markers antibody Alemtuzumab (Anti-CD52) For research use only.
Not for use in humans.

Alemtuzumab (Anti-CD52)

Synonyms: Campath-IH

Alemtuzumab (Anti-CD52) is a humanized monoclonal antibody targeting against CD52. Alemtuzumab selectively targets the CD52 antigen to induce profound lymphocyte depletion, followed by recovery of T and B cells with regulatory phenotypes. MW:145.5 KD.

Alemtuzumab (Anti-CD52)

Purity & Quality Control

Batch: A255301 Purity: 99% Protein concentration: 9.4mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Alemtuzumab (Anti-CD52) is a humanized monoclonal antibody targeting against CD52. Alemtuzumab selectively targets the CD52 antigen to induce profound lymphocyte depletion, followed by recovery of T and B cells with regulatory phenotypes. MW:145.5 KD.

Product Details

CAS No. 216503-57-0
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Alemtuzumab (Anti-CD52) | Alemtuzumab (Anti-CD52) supplier | purchase Alemtuzumab (Anti-CD52) | Alemtuzumab (Anti-CD52) cost | Alemtuzumab (Anti-CD52) manufacturer | order Alemtuzumab (Anti-CD52) | Alemtuzumab (Anti-CD52) distributor